In colorectal cancer (CRC), ligand-receptor signaling axes involving C5a receptor 1 and its ligand RPS19 emerge as key mediators of stromal–tumor crosstalk, providing new mechanistic insights into CRC progression (12). Here, RPS19 is linked to colorectal carcinoma.